The drug has been approved in combination with cisplatin and paclitaxel for the first-line treatment of adult patients with unresectable advanced, recurrent, or metastatic ESCC
The post Dr Reddy's receives DCGI approval for esophageal cancer drug Zytorvi appeared first on Home Page.
